A detailed history of Koshinski Asset Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Koshinski Asset Management, Inc. holds 11,609 shares of NVO stock, worth $1.01 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
11,609
Previous 15,408 24.66%
Holding current value
$1.01 Million
Previous $2.2 Million 37.15%
% of portfolio
0.12%
Previous 0.21%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$119.07 - $145.42 $452,346 - $552,450
-3,799 Reduced 24.66%
11,609 $1.38 Million
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $309,965 - $371,094
2,526 Added 19.61%
15,408 $2.2 Million
Q1 2024

May 08, 2024

SELL
$102.11 - $135.92 $145,506 - $193,685
-1,425 Reduced 9.96%
12,882 $1.65 Million
Q4 2023

Jan 29, 2024

BUY
$87.78 - $105.45 $365,164 - $438,672
4,160 Added 41.0%
14,307 $1.48 Million
Q3 2023

Oct 18, 2023

BUY
$90.94 - $199.54 $424,689 - $931,851
4,670 Added 85.27%
10,147 $922,000
Q2 2023

Jul 28, 2023

SELL
$155.98 - $172.65 $54,904 - $60,772
-352 Reduced 6.04%
5,477 $886,000
Q1 2023

Apr 12, 2023

SELL
$132.34 - $159.14 $418,326 - $503,041
-3,161 Reduced 35.16%
5,829 $927,000
Q4 2022

Jan 24, 2023

BUY
$102.55 - $135.33 $47,993 - $63,334
468 Added 5.49%
8,990 $0
Q3 2022

Oct 20, 2022

BUY
$95.28 - $116.93 $811,976 - $996,477
8,522 New
8,522 $849,000
Q2 2022

Jul 12, 2022

SELL
$103.24 - $121.81 $21,886 - $25,823
-212 Reduced 2.78%
7,426 $827,000
Q1 2022

Apr 20, 2022

SELL
$93.1 - $112.54 $25,416 - $30,723
-273 Reduced 3.45%
7,638 $848 Million
Q4 2021

Jan 14, 2022

SELL
$95.88 - $117.08 $312,760 - $381,914
-3,262 Reduced 29.2%
7,911 $886 Million
Q3 2021

Oct 12, 2021

BUY
$84.42 - $106.62 $703,893 - $888,997
8,338 Added 294.11%
11,173 $1.07 Million
Q2 2021

Jul 26, 2021

SELL
$67.66 - $84.76 $36,265 - $45,431
-536 Reduced 15.9%
2,835 $237,000
Q1 2021

May 06, 2021

SELL
$67.06 - $75.82 $22,330 - $25,248
-333 Reduced 8.99%
3,371 $227,000
Q4 2020

Mar 30, 2021

BUY
$63.89 - $73.8 $16,803 - $19,409
263 Added 7.64%
3,704 $259,000
Q4 2020

Feb 05, 2021

BUY
$63.89 - $73.8 $219,845 - $253,945
3,441 New
3,441 $259,000
Q4 2020

Feb 02, 2021

SELL
$63.89 - $73.8 $234,348 - $270,698
-3,668 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $11,655 - $12,850
183 Added 5.25%
3,668 $270,000
Q2 2020

Jul 29, 2020

SELL
$58.54 - $67.94 $175 - $203
-3 Reduced 0.09%
3,485 $228,000
Q1 2020

Apr 30, 2020

SELL
$49.46 - $64.78 $3,660 - $4,793
-74 Reduced 2.08%
3,488 $210,000
Q4 2019

Jan 29, 2020

SELL
$49.86 - $58.26 $14,309 - $16,720
-287 Reduced 7.46%
3,562 $206,000
Q1 2016

Jan 17, 2018

BUY
N/A
180 Added 4.91%
3,849 $209,000
Q4 2015

Jan 17, 2018

BUY
N/A
3,669
3,669 $213,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.